Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis

Ivan Kiselev1, Ludmila Danilova2, Natalia Baulina1

  • 1Department of Molecular Biology and Medical Biotechnology, Pirogov Russian National Research Medical University, Ostrovityanova st. 1, Moscow 117997, Russian Federation.

Insights

Epigenetic changes in DNA methylation are linked to multiple sclerosis (MS). This study identified specific DNA methylation patterns in immune cells of MS patients, suggesting a role for epigenetics in MS development.

Area of Science:

  • Neuroimmunology
  • Epigenetics
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune CNS disease influenced by genetic and environmental factors.
  • Environmental triggers like infections and smoking may impact DNA methylation, an epigenetic mechanism implicated in MS pathogenesis.
  • Understanding epigenetic alterations in immune cells is crucial for elucidating MS development.

Purpose of the Study:

  • To identify DNA methylation hallmarks associated with multiple sclerosis (MS).
  • To compare genome-wide DNA methylation profiles in immune cells from MS patients and healthy controls.
  • To investigate the role of epigenetic modifications in the development of MS.

Main Methods:

  • Genome-wide DNA methylation profiling was performed using Illumina 450K methylation arrays.
  • Two immune cell populations, CD4+ T-lymphocytes and CD14+ monocytes, were analyzed from treatment-naive relapsing-remitting MS patients and healthy subjects.
  • Differential methylation analysis was conducted to identify MS-associated differentially methylated positions (DMPs).

Main Results:

  • Significant DNA methylation changes were observed in both CD4+ T-lymphocytes and CD14+ monocytes of MS patients.
  • CD4+ cells showed predominantly hypomethylation, while CD14+ cells exhibited hypermethylation in MS.
  • Differential methylation of the HLA-DRB1 gene was associated with the DRB1*15 allele, and approximately 20% of DMPs were shared between cell types.

Conclusions:

  • Epigenetic mechanisms, specifically DNA methylation in immune cells, contribute to the pathogenesis of multiple sclerosis.
  • Identified DNA methylation patterns may serve as biomarkers or targets for future MS research.
  • Further studies are warranted to validate these findings and explore the functional significance of DNA methylation in MS.